The Hindu Business Line : Maxfair Drugs to set up R&D centre at Nasik

MAXFAIR Drugs and Cosmetics Private Ltd, a Nasik-based ayurvedic formulations company, has set a target of Rs 20 crore for the current fiscal. Of which, the company expects Rs 3 crore to come from the southern region.

Launching the company's products in the State, Mr Ranjan Mohapatra, Managing Director of Maxfair, said the company would be setting up a full-fledged research and development centre at Nasik by December at a cost of Rs 2 crore.

Stating that the company was addressing the growing lifestyle-related disorders, he said there were 3.20 crore reported diabetics in the country. "Unreported figures might be more," he said.

Of the 3.20 crore cases, three crore came under non-insulin dependent diabetes. "We are targeting this segment," he said.

The company was planning to launch a product to address sciatica next month. "Other products in the pipeline will address problems like acidity and obesity," he said.

The company's product basket included Diabenol (for diabetes), Damanil (asthma) and Baazigar (sexual dysfunction).

More Stories on : Announcements | Alternative Medicines

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Maxfair Drugs to set up R&D centre at Nasik

Nicholas Piramal to invest Rs 200 cr in R&D, expansion

Revathi Equipment signs PPA with Rajasthan SEB — To set up windmill project

`We want to be biggest in fragrances too'

SAIL may have to relocate stockyards at Bhubaneswar

IMFA Group's ferro chrome production higher

Zacks India chief set to head ICRA's BPO unit

New ED for BHEL (Hyderabad)

New Group GM for HMT unit